首页|评审专家登录|被提名人登录
首页 > 学术前沿
欢迎致电树兰基金
全文下载地址:The serum IL-23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B
上一篇: Genome sequencing and genomic characterization of a tigecycline-resistant Kle…
下一篇: Moderate/Severe Hyponatremia Increases the Risk of Death among Hospitali…